GL1X · GenesisL1 explorer

MolNFT v1 · #62171 · protein

Structure of bovine enos oxygenase domain with inhibitor ar- C95791

3E7S · Nitric oxide synthase, endothelial: “Structure of bovine enos oxygenase domain with inhibitor ar- C95791”. X-ray diffraction, 3 ligands (AT2, HEC, ZN), 13 pockets (best druggability 0.85). MolNFT v1 #62171 on GenesisL1: 3D…

PDB
3E7S
Type
protein
Length
812 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nitric oxide synthase, endothelial
EC
1.14.13.39
UniProt
P29473
Ligands
AT2, HEC, ZN
Pockets
13 · best druggability 0.85

Structure

x-ray diffraction · 2 distinct chains · 39% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANitric oxide synthase, endothelial (EC 1.14.13.39)protein40337% helix, 15% strandP29473
BNitric oxide synthase, endothelial (EC 1.14.13.39)protein40940% helix, 15% strandP29473

Ligands and binding sites

  • AT2 · Ethyl 4-[(4-methylpyridin-2-yl)amino]piperidine-1-carboxylate · ligand · 4 copies · chains A, B
  • HEC · Heme C · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110050.850.8683HEC, AT2
211570.830.8481HEC, AT2
31010.710.9321empty
4860.590.8822empty
5920.550.8518empty

Interfaces

1 interface between chains.

  • A–B · 2922 Ų buried · 49 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 modified (artifact).

Compared structures

  • 3E7S · Structure of bovine eNOS oxygenase domain with inhibitor AR-C95791 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.